all AI news
Structure-based drug design with geometric deep learning. (arXiv:2210.11250v1 [physics.chem-ph])
Oct. 21, 2022, 1:12 a.m. | Clemens Isert, Kenneth Atz, Gisbert Schneider
cs.LG updates on arXiv.org arxiv.org
Structure-based drug design uses three-dimensional geometric information of
macromolecules, such as proteins or nucleic acids, to identify suitable
ligands. Geometric deep learning, an emerging concept of neural-network-based
machine learning, has been applied to macromolecular structures. This review
provides an overview of the recent applications of geometric deep learning in
bioorganic and medicinal chemistry, highlighting its potential for
structure-based drug discovery and design. Emphasis is placed on molecular
property prediction, ligand binding site and pose prediction, and
structure-based de novo molecular …
More from arxiv.org / cs.LG updates on arXiv.org
Testing the Segment Anything Model on radiology data
1 day, 21 hours ago |
arxiv.org
Calorimeter shower superresolution
1 day, 21 hours ago |
arxiv.org
Jobs in AI, ML, Big Data
Software Engineer for AI Training Data (School Specific)
@ G2i Inc | Remote
Software Engineer for AI Training Data (Python)
@ G2i Inc | Remote
Software Engineer for AI Training Data (Tier 2)
@ G2i Inc | Remote
Data Engineer
@ Lemon.io | Remote: Europe, LATAM, Canada, UK, Asia, Oceania
Artificial Intelligence – Bioinformatic Expert
@ University of Texas Medical Branch | Galveston, TX
Lead Developer (AI)
@ Cere Network | San Francisco, US